ATI Physical Therapy EBITDA 2020-2024 | ATIP
ATI Physical Therapy ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| ATI Physical Therapy Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $66 |
| 2022 | $38 |
| 2021 | $69 |
| 2020 | $87 |
| 2019 | $101 |
| ATI Physical Therapy Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $17 |
| 2023-12-31 | $24 |
| 2023-09-30 | $21 |
| 2023-06-30 | $10 |
| 2023-03-31 | $11 |
| 2022-12-31 | $15 |
| 2022-09-30 | $10 |
| 2022-06-30 | $11 |
| 2022-03-31 | $2 |
| 2021-12-31 | $10 |
| 2021-09-30 | $13 |
| 2021-06-30 | $31 |
| 2021-03-31 | $15 |
| 2020-12-31 | |
| 2020-09-30 | $24 |
| 2020-06-30 | $-14 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.020B | $0.699B |
| ATI Physical Therapy Inc. is a portfolio company of Advent International as well as provider of outpatient physical therapy services. ATI Physical Therapy Inc., formerly known as Fortress Value Acquisition Corp. II, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $16.800B | 0.00 |
| Quest Diagnostics (DGX) | United States | $15.206B | 15.72 |
| DaVita (DVA) | United States | $12.153B | 15.10 |
| Encompass Health (EHC) | United States | $8.638B | 22.11 |
| Chemed (CHE) | United States | $8.214B | 25.46 |
| Elanco Animal Health (ELAN) | United States | $7.131B | 18.50 |
| Option Care Health (OPCH) | United States | $4.815B | 18.22 |
| RadNet (RDNT) | United States | $4.353B | 90.65 |
| Amedisys (AMED) | United States | $3.000B | 21.25 |
| Astrana Health (ASTH) | United States | $2.272B | 30.73 |
| Addus HomeCare (ADUS) | United States | $1.901B | 27.19 |
| LifeStance Health (LFST) | United States | $1.877B | 0.00 |
| U.S Physical Therapy (USPH) | United States | $1.393B | 37.27 |
| Pennant (PNTG) | United States | $0.697B | 36.81 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.531B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.223B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.014B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |